It is a box you check at the DMV. And why not? You won’t need ‘em where you are going anyway.
It seems straightforward. But if it were, organ donation would be a unicorn in healthcare: a process unmarred by bureaucracy, institutional pressure, or misaligned incentives. So what actually happens between a catastrophic injury and an organ donation?
Frontier models make it possible for a non-clinical person to investigate a question like this with unusual depth. I used them to trace the process across medical guidelines, federal rules, government investigations, and hospital finance data, then checked the findings against the underlying sources. What emerged was a clearer picture of the uncertain period before donation becomes possible, along with a practical way for patients to decide in advance how they want that uncertainty handled.
A Couple of Notes Before We Get In To It
As this scenario unfolds, it may be tempting to assume that a licensed physician necessarily possesses certainty unavailable to a lay reader. Expertise matters, but expertise cannot make an uncertain prognosis certain. This essay tries to reflect the confidence the evidence actually supports, regardless of who is speaking.
Use of AI in composing this work: I used frontier models to research the organ-donation system, locate primary sources, test claims, and draft the sample advance-directive provision in Addendum A. The writing, argument and composition are my own, and the model-generated language is identified as such.
Act I: Trauma
Imagine a person arrives at the emergency room after a car accident. It looks bad. Neurological damage is suspected but far from confirmed. Death, survival with serious disability, and full recovery all exist somewhere on a probability curve no one yet understands.
Trauma staff work to stabilize the patient, order imaging and laboratory tests, and begin assessing neurological function. The bedside assessment may be performed by a nurse or physician. The Glasgow Coma Scale scores eye opening, verbal response, and motor response. Pupillary and other brainstem reflexes are also assessed.[1]
If those observations meet the hospital’s referral criteria, hospital staff notify the contracted Organ Procurement Organization, or OPO. This is an imminent-death referral. Upon receiving it, the OPO “rapidly goes onsite to determine the medical suitability of the potential donor.”[2]
Before we discuss the OPO and its role, two things are worth noting:
Specialized neurological care is uncommon this early. Even at the country’s best trauma centers, only about a third of patients with severe brain injuries entered dedicated neurological ICUs, and fewer than one in five units were led by a neurointensivist. At Level II centers, only about one in twenty ICUs had one; rural patients often enter through Level III centers, where specialist coverage is thinner still.[3]
The patient’s donor status may not yet be known and doesn’t actually matter much. The clinical trigger, not a donor designation, prompts the referral, so the OPO is contacted regardless.
A Bit About Organ Procurement Organizations
An OPO is a federally certified, nonprofit regional coordinator for deceased organ donation. As of July 2026, the United States had 54 OPOs: 47 independent organizations and 7 based within hospitals. They evaluate referred patients, verify or obtain donation authorization, coordinate organ recovery and preservation, and arrange allocation and transportation to transplant hospitals.[4]
CMS requires Medicare-participating hospitals, nearly all general hospitals, to maintain an agreement with an OPO and notify it of deaths and imminent deaths under that agreement. They have to do it. What stops a hospital from signing the agreement and ignoring it? Government surveyors. Federal or state surveyors can cite the hospital, the OPO, or both for noncompliance, and persistent hospital failures can endanger Medicare participation.[5]
Many details of a hospital’s OPO agreement, including referral criteria, notification deadlines, and payment terms, are neither nationally standardized nor publicly available.
Here is what I could find:
A 2026 study collected referral cards and related trigger materials from nearly every OPO. Of those materials, around 70% used a Glasgow Coma Scale threshold and about half used absent brainstem reflexes. Notification deadlines ranged from immediate referral to four hours, and no two of the ten top OPOs agreed on the same brainstem-reflex criteria.[6]
OPOs reimburse hospitals for authorized services needed to preserve organ viability, including intensive care, operating-room use, laboratory testing, imaging, and organ recovery. For reference, my calculation from 2024 CMS cost reports puts the kidney-allocated share of payments to donor hospitals at about $8,000 per locally procured usable kidney, or roughly $16,000 when two usable kidneys are recovered. I could not find a bulk discount.[7]
Federal rules limit what hospitals can charge OPOs for donor services. The OPO must pay either the hospital’s estimated cost or a rate negotiated with the OPO, whichever is lower. It should not have to pay the hospital’s full listed price.[8]
A defined contractual payer may not sound like a big deal until it is compared with ordinary hospital collections, especially for uninsured patients who receive emergency services and may face the full burden of collection efforts afterward. American hospitals reported $42.67 billion in uncompensated care in 2020, meaning bad debt and financial assistance for care that produced no payment from either a patient or insurer.[9]
In summary, hospital participation with OPOs is mandatory. The operational details, including what counts as imminent death and what the OPO will pay, are murky and can vary, but the payment model for hospitals is far more predictable than patient collections.
Now back to the action.
Act II: Uncertainty
The OPO representative has arrived on scene. OPO personnel may review the medical record without family consent, speak with the clinical team, gather medical and social history, and assess which organs might be medically usable. Without donation authorization or a state-law exception, the OPO should not perform invasive testing. Its personnel may nevertheless be physically present and participating in the workflow while the patient remains under hospital care.[2]
Meanwhile, critical-care decision-making is shaped by stress, fatigue, and limited staffing. Residents, who frequently staff emergency-department and critical-care teams, regularly exceed work-hour limits. Surveys found that roughly half of residents report working beyond duty-hour limits or falsifying their hours. Nearly half of senior residents work more than 60 hours a week, with those longer weeks associated with more than twice the odds of a self-reported medical error.[10]
Even in the best conditions, neurological prognosis is difficult. Declaring brain death is not a quick impression based on a low Glasgow Coma Scale score. It requires a formal examination, an established catastrophic brain injury, the exclusion of confounding factors such as sedatives, intoxication, or paralysis, and apnea testing (can you breathe without a ventilator?) or some other approved test when the clinical examination cannot be completed. Many severely injured patients have not reached that grim certainty when the referral is made.[11]
In a hospital without neurocritical-care coverage, the first framing of prognosis likely comes from emergency, trauma, or general critical-care clinicians without access to a neurointensivist. The family is even further removed, left to interpret cautious and sometimes equivocal language from clinicians who are understandably unwilling to make promises about recovery or death.
The big risk is that an early neurological prognosis can become self-fulfilling when life support is withdrawn before recovery can be tested. Researchers compared these patients with similar patients given more time and estimated that roughly one in four might have survived, including about one in six who could have recovered independently. Nationally, that could mean thousands of avoidable deaths each year.[12]
Observational studies like this can’t fully rule out that early-withdrawal patients were simply sicker. Fine. Cut the estimate in half. Cut it by three quarters. You are still left with hundreds of people per year who died of a prediction rather than an injury, made by exhausted clinicians in hospitals without a neurointensivist in the building.
Act III: Decision
Family members in this immensely unenviable position may be visited by several clinicians, each bringing different information and a different role in the process. Nobody needs to “want the patient’s organs” for the system to shape the available choices, the timing of conversations, and which actions feel professionally routine.
The OPO’s presence complicates the picture, even though it’s not supposed to. CMS safeguards say the attending team and family must address prognosis and withdrawal of treatment before donation is discussed. When family authorization is required, the request must not be rushed, repeated, or coercive, and a refusal must be respected. There are, however, documented cases where these safeguards have failed.[2]
In 2025, the Health Resources and Services Administration reviewed 351 cases handled by the OPO serving Kentucky, Ohio, and West Virginia in which donation had been authorized but not completed. It found concerning features in 103 cases, including 73 patients with neurological signs incompatible with donation. The agency reported that at least 28 patients may not have been dead when procurement was initiated. It also identified poor neurological assessment, weak coordination with medical teams, questionable consent practices, and misclassified causes of death. It concluded, unsurprisingly, that patients at smaller and rural hospitals were the most vulnerable.[13]
CMS followed in March after reports that some OPOs rushed donation discussions and pressured grieving families. Surveyors were told to ask families about pressure and cite the hospital, OPO, or both, even after violations were fixed. The guidance instructed surveyors to determine whether sedatives may have suppressed neurological responsiveness and required procurement to stop immediately if a declared-dead patient showed signs of life.[14]
Is Organ Donation Still Worth Supporting?
Most likely. In 2024, 17,000 deceased donors made 41,000 transplants possible.[15]
Federal data still do not tell us how many of those cases passed through a genuinely uncertain prognosis before death or withdrawal; HRSA only recently began collecting standardized information about what happens between OPO referral and death.[16]
The most useful thing you can do costs nothing: don’t leave your family guessing in the gray zone. A standard DNR doesn’t cover this scenario. It addresses resuscitation, but not the decision to withdraw support amid an uncertain neurological prognosis. An advance directive is a legal document stating your treatment wishes. It can be carried out by a designated healthcare agent, a person you appoint to enforce them, and can cover exactly this. Sample language addressing the concerns in this essay appears in the addendum below.
The box at the DMV decides what happens after your death. An advance directive gives you a chance to define what happens in the gray zone before it. AI can help you work through those choices and put them into words while you still can.
Addendum A: Advance Directive Sample Provision
Generated by Anthropic’s Claude Fable 5 High
The easiest way to act on this is to put this entire essay, including this addendum, into Claude (please use a good model like Opus 5 or Fable, not Sonnet or Haiku) and ask it to interview you about what you want in a full advance directive, including the following provision.
Sample provision: severe brain injury with uncertain prognosis
If I suffer a severe brain injury and my prognosis is uncertain, I direct the following:
Observation period. Life-sustaining treatment shall be continued for a minimum of 72 hours [or: 7 days] following the injury before any decision to withdraw it is made, unless death has been formally declared under accepted neurological criteria, including a complete clinical examination and apnea testing or an approved ancillary test.
Specialist consultation. Before any withdrawal decision, I request evaluation by a physician with specialty training in neurology, neurosurgery, or neurocritical care, using telemedicine if none is available at the treating hospital.
Confounder review. No neurological prognosis used to justify withdrawal should be made while sedatives, paralytics, intoxicants, or hypothermia could plausibly be suppressing my responsiveness.
Separation of conversations. I direct that no organ donation discussion occur with my family or agent until after my care team and my agent have fully addressed prognosis and any withdrawal decision, consistent with federal guidance. My healthcare agent is authorized to ask any person in the room to identify their employer and role.
Donation intent. My willingness to be an organ donor is unchanged. [Strike or modify this sentence if you are not a registered donor.] This provision does not revoke my donor designation; it governs only the timing and sequence of decisions while my survival remains in question.
The agent’s power is consent. Once you’re incapacitated, the agent legally stands in your shoes: withdrawal of life support (short of a formal brain-death declaration) generally requires the consent of the patient’s decision-maker, and the agent is that decision-maker. So:
Enforcing point 1 (observation period): The agent simply declines to consent to withdrawal before 72 hours. That’s it. No one has to be persuaded; withdrawal without decision-maker consent isn’t an option the hospital has.
Enforcing point 2 (specialist consult): The agent can’t order a consult, but can condition consent on one: “I’m not authorizing any withdrawal decision until a neurologist or neurointensivist, by telemedicine if necessary, has evaluated him.” Hospitals can arrange tele-neurology; a documented request from the legal decision-maker, backed by a written directive, is very hard to ignore, and refusing it creates paper the hospital doesn’t want.
Enforcing point 3 (confounder review): The agent asks a specific question and waits for a specific answer: “What sedatives is she on, when was the last dose, and are you confident the exam reflects her brain and not the drugs?” If the answer is vague, the agent declines consent until it isn’t. Point 3 essentially converts a directive clause into a script for that question.
Escalation tools if stonewalled: Request the hospital ethics committee (every accredited hospital has one and any family member can invoke it), request a second opinion, request transfer to a higher-level center, and put objections in writing so they enter the record.
Addendum B: What the Public Records Should Show
Neither trust nor distrust is a substitute for the underlying records. The public summaries do not identify the hospitals, disclose the 351 case files, or show how responsibility was divided among hospital staff, OPO personnel, and recovery teams. The government has released its conclusions, but not enough evidence for the public to reconstruct these cases independently. The answer is to obtain the records and test the claims.
Freedom of Information Act and state public-records requests offer an opportunity for more clarity and independent review of these conclusions. Relevant documents include:
The de-identified 351-case review database, including hospital identifiers, timelines, neurological findings, reported signs of life, staff objections, donation stoppages, outcomes, and corrective actions.
Complete hospital-OPO agreements, including referral-trigger definitions, notification deadlines, family-approach rules, transfer-of-control language, onsite staffing or leased-space arrangements, and every reimbursement exhibit or financial addendum.
CMS and state survey workpapers, complaints, deficiency reports, plans of correction, and correspondence involving organ-donation pressure, premature withdrawal discussions, death determination, or continued procurement after signs of life.
OPO invoice registers and hospital accounts-receivable records showing amounts billed, allowed, paid, denied, disputed, and written off for donor services.
Comparable hospital collection data for the same intensive-care, laboratory, imaging, anesthesia, and operating-room services when the payer was commercial insurance, Medicare, Medicaid, or an uninsured patient.
Hospital-level referral totals, missed-referral findings, authorization rates, donation stoppages, and reviews of deaths that did not produce an OPO referral.
Addendum C: Calculation of Amount Reimbursed to Donor Hospitals for Usable Kidney Procurement
The $8,000 figure is a national weighted average from 49 independent OPOs’ 2024 CMS cost reports:
$160.8 million paid to donor hospitals for kidney procurement / 20,135 locally recovered usable kidneys = $7,988 per kidney.
This represents the kidney-allocated share of hospital payments, not a fixed reimbursement rate or the complete cost of a donor’s care.
Sources
StatPearls, “Glasgow Coma Scale”: https://www.ncbi.nlm.nih.gov/books/NBK513298/
CMS, QSO-26-05: https://www.cms.gov/files/document/qso-26-05-opo-original-release-date-2026-03-11-pdf.pdf
Journal of Neurotrauma: https://journals.sagepub.com/doi/full/10.1089/neu.2017.4997
Health Resources and Services Administration, OPTN membership: https://www.hrsa.gov/optn/about/membership
42 C.F.R. § 482.45: https://www.law.cornell.edu/cfr/text/42/482.45; CMS, QSO-26-05: https://www.cms.gov/files/document/qso-26-05-opo-original-release-date-2026-03-11-pdf.pdf
Frontiers in Transplantation: https://www.frontiersin.org/journals/transplantation/articles/10.3389/frtra.2026.1701648/full
CMS OPO Cost Reports: https://www.cms.gov/data-research/statistics-trends-reports/cost-reports/organ-procurement-organization; CMS Form 216-94: https://www.cms.gov/regulations-and-guidance/legislation/paperworkreductionactof1995/pra-listing-items/cms-216-94
42 C.F.R. § 413.418: https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-413/subpart-L/section-413.418
American Hospital Association: https://www.aha.org/fact-sheets/2020-01-06-fact-sheet-uncompensated-hospital-care-cost
Journal of Graduate Medical Education: https://pmc.ncbi.nlm.nih.gov/articles/PMC3771164/; BMJ Medicine: https://bmjmedicine.bmj.com/content/2/1/e000320
American Academy of Neurology consensus guideline: https://www.neurology.org/doi/10.1212/WNL.0000000000207740
Resuscitation: https://pubmed.ncbi.nlm.nih.gov/26836944/
HHS and HRSA investigation summary: https://www.hhs.gov/press-room/hrsa-to-reform-organ-transplant-system.html
CMS press release: https://www.cms.gov/newsroom/press-releases/cms-strengthens-patient-protections-accountability-organ-donation-system; CMS, QSO-26-05: https://www.cms.gov/files/document/qso-26-05-opo-original-release-date-2026-03-11-pdf.pdf
Health Resources and Services Administration, 2024 transplant totals: https://www.hrsa.gov/optn/news-events/news/organ-transplants-exceeded-48000-2024-33-percent-increase-transplants-performed-2023
Health Resources and Services Administration, procurement-safety initiative: https://www.hrsa.gov/optn/policies-bylaws/policy-issues/strengthening-organ-donation-and-procurement-safety